Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-23
2000-07-25
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, A61K 3144, C07D47104
Patent
active
060937289
ABSTRACT:
The present invention is directed in part towards methods of modulating the function of serine/threonine protein kinases with azabenzimidazole-based compounds. The methods incorporate cells that express a serine/threonine protein kinase, such as RAF. In addition, the invention describes methods of preventing and treating serine/threonine protein kinase-related abnormal conditions in organisms with a compound identified by the invention. Furthermore, the invention pertains to azabenzimidazole compounds and pharmaceutical compositions comprising these compounds.
REFERENCES:
patent: 3590045 (1971-06-01), Vogt et al.
patent: 4247556 (1981-01-01), Von Bebenburg
patent: 5217999 (1993-06-01), Levitzki et al.
patent: 5302606 (1994-04-01), Spada et al.
patent: 5330992 (1994-07-01), Eissenstat et al.
Bonner et al., "Structure and Biological Activity of Human Homologs of the raf/mil Oncogene," Molecular and Cellular Biology 5:1400-1407 (1985).
Folkman, "What is the Evidence that Tumors are Angiogenesis Dependent?" Journal of the National Cancer Institute 82:4-6 (1990).
Monia et al., "Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase," Nature Medicine 2:668-675 (1996).
Morrison et al., "Signal Transduction From Membrane to Cytoplasm: Growth Factors and Membrane-Bound Oncogene Products Increase Raf-1 Phosphorylation and Associated Protein Kinase Activity," Proc. Natl. Acad. Sci. USA 85:8855-8859 (1988).
Robbins et al., "Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro," J. Biol. Chem. 268:5097-5106 (1993).
App Harald
Kutscher Bernhard
McMahon Gerald
Weinberger Heinz
Asta Medica Aktiengesellschaft
Dentz Bernard
LandOfFree
Methods of modulating serine/threonine protein kinase function w does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating serine/threonine protein kinase function w, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating serine/threonine protein kinase function w will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1336877